NanoSphere’s novel retail products and technology present maximum absorbency of cannabinoids for consumers.Read More
The U.S. cannabis industry is projected to exceed $50 billion in size over the coming years, according to Cowen & Co., driven by the legalization of adult-use cannabis in California and other states. While there are many opportunities for investors in the space, since they generate high-margin licensing revenue and don’t touch the plant, biotech firms developing innovative delivery mechanisms offer investors a compelling opportunity.Read More
Demand for the Company's Groundbreaking Transdermal Evolve NanoSerum™ Driving ProductionRead More
NanoSphere Health Sciences Inc., based in Denver, focused on nutraceuticals & supplements, cannabis, pharmaceuticals, OTCs, cosmetics, and animal health products, today announced that the January 18 presentation from Victor Goncalves, Executive Vice President, and Dr. Richard Kaufman, Chief Science Officer, is now available for on-demand viewing at VirtualInvestorConferences.com.Read More
NanoSphere Health Sciences Inc. (CSE: NSHS, “NanoSphere”) is pleased to announce that it has signed an agreement to license its technology, as it pertains to cannabis products, in the State of California.
NanoSphere Health Sciences Inc. (CSE: NSHS, "NanoSphere") is pleased to announce that it has been nominated for the National Cannabis Industry Association's Excellence in Technology Award in Infused Products and Extraction.Read More
NanoSphere Health Sciences Inc. (CSE: NSHS) ("NanoSphere") (formerly Corazon Gold Corp.) is pleased to announce a name change and listing on the Canadian Securities Exchange (the "CSE"), effective today. NanoSphere's shares will commence trading tomorrow, December 5, 2017, under the symbol "NSHS".Read More
Corazon Gold Corp. (the “Company”) and NanoSphere Health Sciences, LLC (“NanoSphere”) are pleased to announce the closing of the Company’s private placement (the “Offering”) for gross proceeds of $5,905,685, and the completion of the Company’s acquisition (the “Acquisition”) of NanoSphere.Read More
According to the Anxiety and Depression Association of America, approximately 18 percent of Americans suffer from some form of anxiety disorder.Read More
The commercial sale of marijuana products began in 2014, following the historic vote in Colorado and Washington in November of 2012. The economic impact has been significant and wide-spread throughout the two states ever since. Now in 2017, we are up to eight states that have legalized marijuana for recitational use, and 20 others where marijuana is legalized for medical use.Read More
We are pleased to announce that we have completed our due diligence and have signed a Binding Merger Agreement dated May 18th, 2017 with Corazon Gold Corp. (CGW: TSX-V) for 100% acquisition of NanoSphere’s issued and outstanding shares.Read More
Current delivery methods are inferior, but great things are coming.
Colorado and Washington became the first states to legalize cannabis for recreational use in 2012, since then, six others have followed suit, and more are sure to come.Read More
Opioids are one of the most commonly prescribed medicine to treat severe chronic pain.
- Addiction to and abuse of pharmaceutical opiates is a widespread and growing health issue
We are pleased to announce that we have signed a Letter of Intent dated December 22, 2016, with Corazon Gold Corp. (TSX VENTURE: CGW) for 100% acquisition of NanoSphere’s issued and outstanding shares.Read More